ArticleInternational journal of oncology2015

TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.

Pavla Brachova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.